Peter A. Pinto, M.D.

Peter A. Pinto, M.D.
Investigator
Urologic Oncology Branch
Head, Prostate Cancer Section

Dr. Pinto is an Investigator and faculty member in the Urologic Oncology Branch of the National Cancer Institute, National Institutes of Health in Bethesda, Md. Following a residency in Urologic Surgery at Long Island Jewish Medical Center - Albert Einstein College of Medicine in New York, he was a Fellow and Clinical Instructor at the Brady Urologic Institute, Johns Hopkins Hospital. Dr. Pinto is a Board Certified Urologic Surgeon specializing in oncology and is the Director of the Urologic Oncology Fellowship Program at the National Cancer Institute. He is nationally and internationally recognized as an expert in the minimally invasive treatment of urologic cancers, specializing in laparoscopic and robotic surgery for prostate, kidney, bladder, and testicular cancer.

Areas of Expertise

1) urologic cancers, 2) laparoscopy, 3) robotic surgery

     Get patient info

Contact Info

Peter A. Pinto, M.D.
Center for Cancer Research
National Cancer Institute
Building 10, Hatfield CRC, Room 2W-5940
Bethesda, MD 20892
Ph: 240-858-7200
pintop@mail.nih.gov

Dr. Pinto’s scientific mission is development of novel diagnostic and treatment modalities for localized and locally advanced prostate cancer.

Research efforts are centered on investigation of multiparametric MRI (mpMRI) in prostate cancer to improve diagnosis with mpMRI whole-mount pathology correlation and creation of a tumor-directed biopsy device; development of image-guided focal prostate cancer therapy; and evaluation of immunotherapy, molecular targeted therapy or other pharmacotherapies in the management of localized or locally advanced prostate cancer.

 

NIH Scientific Focus Areas:
Biomedical Engineering and Biophysics, Clinical Research
View Dr. Pinto's PubMed Summary.

Selected Recent Publications

  1. MRI-Targeted, Systematic, and Combined Biopsy for Prostate Cancer Diagnosis.
    Ahdoot M, Wilbur AR, Reese SE, Lebastchi AH, Mehralivand S, Gomella PT, Bloom J, Gurram S, Siddiqui M, Pinsky P, Parnes H, Linehan WM, Merino M, Choyke PL, Shih JH, Turkbey B, Wood BJ, Pinto PA.
    New Engl J Med. 382(10): 917-28, 2020. [ Journal Article ]
  2. Neoadjuvant PROSTVAC prior to radical prostatectomy enhances T-cell infiltration into the tumor immune microenvironment in men with prostate cancer.
    Abdul Sater H, Marté JL, Donahue RN, Walter-Rodriguez B, Heery CR, Steinberg SM, Cordes LM, Chun G, Karzai F, Bilusic M, Harmon SA, Turkbey IB, Choyke PL, Schlom J, Dahut WL, Madan RA, Pinto PA, Gulley JL.
    J Immunother Cancer. 8(1): e000655, 2020. [ Journal Article ]
  3. The role of multiparametric MRI in biopsy-naive prostate cancer.
    Lebastchi AH, Pinto PA.
    Nat Rev Urol. 16(5): 276-77, 2019. [ Journal Article ]
  4. Analyzing the current practice patterns and views among urologists regarding focal therapy for prostate cancer.
    Jain AL, Sidana A, Maruf M, Sugano D, Calio B, Wood BJ, Pinto PA.
    Urol Oncol. 37(3): 182.e1-182.e8, 2019. [ Journal Article ]
  5. A Magnetic Resonance Imaging-Based Prediction Model for Prostate Biopsy Risk Stratification.
    Mehralivand S, Shih JH, Rais-Bahrami S, Oto A, Bednarova S, Nix JW, Thomas JV, Gordetsky JB, Gaur S, Harmon SA, Siddiqui MM, Merino MJ, Parnes HL, Wood BJ, Pinto PA, Choyke PL, Turkbey B.
    JAMA Oncol. 4(5): 678-85, 2018. [ Journal Article ]

Dr. Pinto is an Investigator and faculty member in the Urologic Oncology Branch of the National Cancer Institute, National Institutes of Health in Bethesda, Md. Following a residency in Urologic Surgery at Long Island Jewish Medical Center - Albert Einstein College of Medicine in New York, he was a Fellow and Clinical Instructor at the Brady Urologic Institute, Johns Hopkins Hospital. Dr. Pinto is a Board Certified Urologic Surgeon specializing in oncology and is the Director of the Urologic Oncology Fellowship Program at the National Cancer Institute. He is nationally and internationally recognized as an expert in the minimally invasive treatment of urologic cancers, specializing in laparoscopic and robotic surgery for prostate, kidney, bladder, and testicular cancer.

Position Degree Required Contact Name E-mail Address
Clinical Fellow - urology, oncology, fellowship, training M.D. or equivalent Peter Pinto pintop@mail.nih.gov
Name Position
Julian Custer Research Biologist (Contr.)
Toneisia Gross R.N. Research Nurse
Luis Nunez Patient Care Coordinator (Contr.)
Lerkia Parks Patient Care Coordinator (Contr.)
Charlotte Payne P.A. Physician Assistant
Michele Reed R.N. Research Nurse
Hema Sethumadhavan Data Manager (Contr.)
Bryant Villavicencio Patient Care Coordinator (Contr.)
Nana Yaqub-Ogun P.A. Physician Assistant
Search all
CCR clinical trials
Jack Bilby
Milestones 2021: Better Together to Diagnose Prostate Cancer
Wild-type human prostate cells from an organoid
Milestones 2017: Seeing Prostate Cancer More Clearly
Peter Pinto, M.D., and Peter Choyke, M.D., use UroNav to improve accuracy of prostate cancer imaging.
Landmarks: Precise Clinical Imaging of Tumors